Conditions: Type 1 Diabetes Mellitus; Type 1 Diabetes Mellitus With Hypoglycemia; Drive
Interventions: Device: MiniMed 780 G
Sponsors: University Hospital, Motol
Not yet recruiting
Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
AI-Powered Health Tools
Interactive AI Tools to Help You Understand Your Health
-
Palpitations? Use AI to assess if it’s anxiety or arrhythmia
-
Tonsil swelling checker: Infection, irritation, or chronic condition?
-
Burning during urination? Input symptoms for a fast AI analysis
-
Interpret your tumor marker test: Enter CA-125, PSA, or CEA for analysis
-
Check your oxygen saturation: Enter SpO2 for AI-guided interpretation
-
Check for constipation type: AI helps identify cause and solution
-
Memory problems: Assess your cognitive health with our AI quiz
-
Blood in stool or urine? Use AI bot to assess if it’s a cancer warning sign
-
Voice loss analyzer: AI checks for overuse vs. infection vs. nodules
-
Check for early diabetic kidney damage: AI screens lab and lifestyle data
-
Is it normal numbness or nerve damage? Enter affected area for instant feedback
-
Nerve pain or muscle issue? Use AI checker for accurate symptom matching
Solutions for Smart Healthcare
Clinical Research
-
Cognitive complexity explains processing asymmetry in judgments of similarity versus difference
“`html Research Summary: Understanding Human Judgments of Similarity and Difference In a recent study published in Cognition Psychology, researchers investigated the asymmetry in human judgments of similarity and difference. They…
-
Drug Development
Drug Development LatAm-FINGERS Trial Overview The LatAm-FINGERS trial is a groundbreaking clinical study involving participants from 12 Latin American countries. This trial focuses on providing inclusive and diverse recruitment, especially…
-
Effect of integrating traditional and modern healthcare systems on tuberculosis case detection in Ethiopia: a cluster randomized controlled study
Background Detecting tuberculosis (TB) cases is crucial for controlling the disease, especially in countries like Ethiopia where TB is common. This study looked at combining traditional and modern TB care…
-
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma
Developing a Fit-for-Purpose Composite Symptom Score for Malignant Pleural Mesothelioma Clinical Trials Key Practical Solutions and Value We developed a composite symptom score (CSS) to measure disease-related symptom burden in…
-
Primary Arterial Hypertension Associated with Cognitive Dysfunction in Young Adults: Results from a Cross-Sectional Controlled Study
“`html Primary Arterial Hypertension and Cognitive Function in Young Adults Key Findings: Young adults with primary hypertension (PH) showed poorer performance in tasks of response speed and sustained attention compared…
-
Using structural equation model to analyse the effect of psychological pressure on the patients with essential hypertension blood pressure and blood biochemical indicators
Background Essential hypertension (EH) is influenced by both environmental and genetic factors. Many risk factors exist, and psychological stress is believed to play a role in developing EH. Methods We…
-
Shortness of breath on exertion? Check for early signs of heart failure
How the Chatbot Works If you’ve ever felt winded after climbing stairs or doing light chores, you’re not alone. This chatbot helps you understand whether shortness of breath during activity…
-
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study ABSTRACT Researchers studied the sensitivity of Clinical Dementia Rating (CDR) in measuring pre-symptomatic Alzheimer’s…
-
Clinical Manifestations
Clinical Manifestations Background Cognitive issues affect about 40% of people with heart failure (HF). This study looks at how patients with HF view their cognitive abilities and how these views…
-
Impact of a 12-Week Dietary Intervention on Adipose Tissue Metabolic Markers in Overweight Women of Reproductive Age
Impact of a 12-Week Dietary Intervention on Adipose Tissue Metabolic Markers in Overweight Women of Reproductive Age Study Overview The study aimed to assess the effects of a 12-week dietary…
-
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial
Clinical Trial Summary: 10% Intravenous Immunoglobulin (IVIG) for ITP Study Overview A recent clinical trial tested a new 10% IVIG treatment for adults with persistent or chronic primary immune thrombocytopenia…
-
Researchers at Microsoft Introduces VASA-1: Transforming Realism in Talking Face Generation with Audio-Driven Innovation
**Title: VASA-1: Revolutionizing Realistic Talking Face Generation with Audio-Driven AI Innovation** Practical AI Solutions for Your Business In today’s multimedia and communication landscape, AI-generated talking faces hold immense potential for…
-
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I) Key…
-
Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study
Background There are few effective treatments for older patients with acute myeloid leukemia (AML). A study was done to test a new treatment combining pegylated liposomal doxorubicin (PLD), low-dose cytarabine…
